Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2509371rdf:typepubmed:Citationlld:pubmed
pubmed-article:2509371lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:2509371lifeskim:mentionsumls-concept:C0033809lld:lifeskim
pubmed-article:2509371lifeskim:mentionsumls-concept:C0003250lld:lifeskim
pubmed-article:2509371lifeskim:mentionsumls-concept:C0003316lld:lifeskim
pubmed-article:2509371lifeskim:mentionsumls-concept:C0023810lld:lifeskim
pubmed-article:2509371lifeskim:mentionsumls-concept:C0204727lld:lifeskim
pubmed-article:2509371lifeskim:mentionsumls-concept:C0205409lld:lifeskim
pubmed-article:2509371lifeskim:mentionsumls-concept:C1522138lld:lifeskim
pubmed-article:2509371lifeskim:mentionsumls-concept:C0456570lld:lifeskim
pubmed-article:2509371lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:2509371pubmed:issue12lld:pubmed
pubmed-article:2509371pubmed:dateCreated1989-12-21lld:pubmed
pubmed-article:2509371pubmed:abstractTextA hybridoma line secreting a human monoclonal antibody (HMAb) capable of recognizing Fisher immunotype (IT) 1, 3, 4, and 6 lipopolysaccharide (LPS) in vitro was isolated. Peripheral blood lymphocytes (PBL) were obtained from volunteers immunized with an experimental Pseudomonas aeruginosa O polysaccharide-toxin A vaccine. PBL-expressing surface antibodies able to bind to P. aeruginosa LPS were isolated by adsorption onto LPS-coated plastic wells. Such PBL were transformed with Epstein-Barr virus. Lymphoblastoid cell lines secreting anti-P. aeruginosa LPS antibodies were identified by an enzyme-linked immunosorbent assay and fused to the F3B6 heteromyeloma line. A hybridoma line producing a HMAb (2-8AH79) able to bind IT-1, IT-3, IT-4, and IT-6 LPS was identified by an enzyme-linked immunosorbent assay. This HMAb was found to bind to the O-polysaccharide regions of IT-1, IT-3, IT-4, and IT-6 LPS, as determined by immunoblotting. By using an immunofluorescence microscopy assay, the cell surfaces of IT-3 and IT-4 bacteria were strongly stained by HMAb 2-8AH79, whereas those of IT-1 and IT-6 bacteria were weakly stained. This HMAb was found to promote the uptake and killing of IT-3 and IT-4 bacteria, but not IT-1 or IT-6 organisms, by human polymorphonuclear leukocytes. Similarly, the passive transfer of HMAb 2-8AH79 to mice afforded significant protection only against a challenge with IT-3 and IT-4 bacteria.lld:pubmed
pubmed-article:2509371pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2509371pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2509371pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2509371pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2509371pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2509371pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2509371pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2509371pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2509371pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2509371pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2509371pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2509371pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2509371pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2509371pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2509371pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2509371pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2509371pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2509371pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2509371pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2509371pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2509371pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2509371pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2509371pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2509371pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2509371pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2509371pubmed:languageenglld:pubmed
pubmed-article:2509371pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2509371pubmed:citationSubsetIMlld:pubmed
pubmed-article:2509371pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2509371pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2509371pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2509371pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2509371pubmed:statusMEDLINElld:pubmed
pubmed-article:2509371pubmed:monthDeclld:pubmed
pubmed-article:2509371pubmed:issn0019-9567lld:pubmed
pubmed-article:2509371pubmed:authorpubmed-author:LarrickJ WJWlld:pubmed
pubmed-article:2509371pubmed:authorpubmed-author:FürerEElld:pubmed
pubmed-article:2509371pubmed:authorpubmed-author:LangA BABlld:pubmed
pubmed-article:2509371pubmed:authorpubmed-author:CryzS JSJJrlld:pubmed
pubmed-article:2509371pubmed:issnTypePrintlld:pubmed
pubmed-article:2509371pubmed:volume57lld:pubmed
pubmed-article:2509371pubmed:ownerNLMlld:pubmed
pubmed-article:2509371pubmed:authorsCompleteYlld:pubmed
pubmed-article:2509371pubmed:pagination3851-5lld:pubmed
pubmed-article:2509371pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:2509371pubmed:meshHeadingpubmed-meshheading:2509371-...lld:pubmed
pubmed-article:2509371pubmed:meshHeadingpubmed-meshheading:2509371-...lld:pubmed
pubmed-article:2509371pubmed:meshHeadingpubmed-meshheading:2509371-...lld:pubmed
pubmed-article:2509371pubmed:meshHeadingpubmed-meshheading:2509371-...lld:pubmed
pubmed-article:2509371pubmed:meshHeadingpubmed-meshheading:2509371-...lld:pubmed
pubmed-article:2509371pubmed:meshHeadingpubmed-meshheading:2509371-...lld:pubmed
pubmed-article:2509371pubmed:meshHeadingpubmed-meshheading:2509371-...lld:pubmed
pubmed-article:2509371pubmed:meshHeadingpubmed-meshheading:2509371-...lld:pubmed
pubmed-article:2509371pubmed:meshHeadingpubmed-meshheading:2509371-...lld:pubmed
pubmed-article:2509371pubmed:meshHeadingpubmed-meshheading:2509371-...lld:pubmed
pubmed-article:2509371pubmed:meshHeadingpubmed-meshheading:2509371-...lld:pubmed
pubmed-article:2509371pubmed:meshHeadingpubmed-meshheading:2509371-...lld:pubmed
pubmed-article:2509371pubmed:meshHeadingpubmed-meshheading:2509371-...lld:pubmed
pubmed-article:2509371pubmed:meshHeadingpubmed-meshheading:2509371-...lld:pubmed
pubmed-article:2509371pubmed:meshHeadingpubmed-meshheading:2509371-...lld:pubmed
pubmed-article:2509371pubmed:year1989lld:pubmed
pubmed-article:2509371pubmed:articleTitleIsolation and characterization of a human monoclonal antibody that recognizes epitopes shared by Pseudomonas aeruginosa immunotype 1, 3, 4, and 6 lipopolysaccharides.lld:pubmed
pubmed-article:2509371pubmed:affiliationSwiss Serum and Vaccine Institute, Bern.lld:pubmed
pubmed-article:2509371pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2509371lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2509371lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2509371lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2509371lld:pubmed